- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/58 - Nitrogen atoms attached in position 4
Patent holdings for IPC class C07D 211/58
Total number of patents in this class: 823
10-year publication summary
|
67
|
71
|
51
|
67
|
53
|
52
|
50
|
57
|
46
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2712 |
29 |
| The Regents of the University of California | 19857 |
22 |
| ACADIA Pharmaceuticals Inc. | 206 |
20 |
| BASF SE | 20892 |
13 |
| Boehringer Ingelheim International GmbH | 4697 |
12 |
| Incyte Corporation | 1018 |
12 |
| AstraZeneca AB | 2928 |
11 |
| Helsinn Healthcare SA | 225 |
9 |
| Incyte Holdings Corporation | 651 |
9 |
| Rigel Pharmaceuticals, Inc. | 539 |
9 |
| Janssen Pharmaceutica N.V. | 3396 |
8 |
| Dana-Farber Cancer Institute, Inc. | 2558 |
8 |
| Suzhou Abogen Biosciences Co., Ltd. | 73 |
8 |
| F. Hoffmann-La Roche AG | 7934 |
7 |
| Astellas Pharma Inc. | 1088 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 868 |
7 |
| Alkermes, Inc. | 137 |
6 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2149 |
6 |
| Exigence Technologies Inc. | 9 |
6 |
| Mirati Therapeutics, Inc. | 248 |
6 |
| Other owners | 608 |